TIM-3: An emerging target in the liver diseases

Area of Science:

• Immunology
• Hepatology
• Molecular Biology

Background:

• T cell immunoglobulin domain and mucin domain-containing molecule 3 (TIM-3) is a type I transmembrane protein expressed on terminally differentiated T cells.
• TIM-3 interacts with Galectin-9, mediating T cell apoptosis and immune peripheral tolerance.
• TIM-3 expression extends to Th17 cells, NK cells, and monocytes, influencing immune regulation.

Purpose of the Study:

• To summarize the critical role of TIM-3 in the regulation of liver diseases.
• To explore the potential of TIM-3 as a therapeutic target for liver disease intervention.
• To review the current understanding and future prospects of TIM-3 in clinical research.

Main Methods:

• Literature review of studies investigating TIM-3 expression and function in liver disease.
• Analysis of research on TIM-3's interaction with ligands like Galectin-9.
• Synthesis of data on TIM-3's influence on various liver conditions, including viral infections, fibrosis, and cancer.

Main Results:

• TIM-3 is implicated in the pathogenesis and progression of diverse liver diseases.
• TIM-3's inhibitory effects in vivo are established, though specific mechanisms require further elucidation.
• Targeted therapy involving TIM-3 is emerging as a novel immunotherapeutic strategy.

Conclusions:

• TIM-3 significantly influences liver disease development and progression.
• Understanding TIM-3's precise mechanisms is crucial for developing effective interventions.
• TIM-3 presents a promising target for improving clinical outcomes in liver disease.